TAMMY HOWERTON: Open Payments
NPI 1285619940 · DEFUNIAK SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 32 payments from 11 companies in 2025. Trend: 2023 $235 · 2024 $928 · 2025 $780
Food & beverage: $664Education: $116
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $261 |
| Novo Nordisk Inc | 8 | $227 |
| ABBVIE INC. | 5 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: AIRSUPRA, Ozempic, FARXIGA, VRAYLAR, XIFAXAN, REXULTI, ZEPBOUND, Kerendia.
Industry payments across FL — which companies pay providers there.
